Apolipoprotein AI isoforms in serum determined by isoelectric focusing and immunoblotting

被引:13
作者
Contiero, E
Ferrari, R
Vaselli, GM
Folin, M
机构
[1] UNIV PADUA,DEPT BIOL,I-35121 PADUA,ITALY
[2] CAMPOSAMPIERO HOSP,TRANSFUS CTR,PADUA,ITALY
关键词
apolipoprotein AI isoforms; immunoblotting; isoelectric focusing; HIGH-DENSITY LIPOPROTEIN; FRACTIONAL CATABOLIC RATE; CORONARY-ARTERY DISEASE; CHOLESTEROL LEVELS; INVIVO METABOLISM; TANGIER DISEASE; I CONVERSION; APOA-I; FRAMINGHAM;
D O I
10.1002/elps.1150180123
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Quantitative evaluation of serum apolipoprotein AI (ape AI) isoforms through densitometric analysis following isoelectric focusing (IEF) is described. The apo AI isoforms were identified by immunoblotting. By combining these techniques, a qualitatively invariant pattern was observed in 54 serum samples, obtained from 27 men and 27 women. Peak 1 (proapo AI, pI 5.75) accounts for about 8% of the total densitometric area, peak 3 (ape AI(0), pI 5.59) for about 74%, peak 4 (ape AI(-1), pI 5.42) for about 13%, and peak 5 (ape AI(-2), pI 5.37) for about 5%. In some subjects, the proportion of proapo AI was increased. Variations of the ratio of the different apo AI isoforms may be due to modification of the fractional catabolic rate of this apolipoprotein. The procedure proposed in this study may be useful for the evaluation of quantitative abnormalities in apo AI isoforms involved in the development of coronary heart diseases (CHD).
引用
收藏
页码:122 / 126
页数:5
相关论文
共 31 条
[1]   HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, TOTAL CHOLESTEROL SCREENING, AND MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY [J].
ABBOTT, RD ;
WILSON, PWF ;
KANNEL, WB ;
CASTELLI, WP .
ARTERIOSCLEROSIS, 1988, 8 (03) :207-211
[2]   GENES AND DYSLIPOPROTEINAEMIAS [J].
ASSMANN, G .
EUROPEAN HEART JOURNAL, 1990, 11 :4-8
[3]  
AVOGARO P, 1979, LANCET, V1, P901
[4]   INVIVO METABOLISM OF PROAPOLIPOPROTEIN-A-I IN TANGIER DISEASE [J].
BOJANOVSKI, D ;
GREGG, RE ;
ZECH, LA ;
MENG, MS ;
BISHOP, C ;
RONAN, R ;
BREWER, HB .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1742-1747
[5]  
BOJANOVSKI D, 1985, J LIPID RES, V26, P185
[6]  
BREWER HB, 1986, METHOD ENZYMOL, V128, P223
[7]   ELEVATED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS CORRELATE WITH DECREASED APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-A-II FRACTIONAL CATABOLIC RATE IN WOMEN [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :262-269
[8]   INCREASED APO-A-I AND APO-A-II FRACTIONAL CATABOLIC RATE IN PATIENTS WITH LOW HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS WITH OR WITHOUT HYPERTRIGLYCERIDEMIA [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) :536-544
[9]  
EDELSTEIN C, 1983, J BIOL CHEM, V258, P1430
[10]   DEMONSTRATION THAT THE ENZYME THAT CONVERTS PRECURSOR OF APOLIPOPROTEIN-A-I TO APOLIPOPROTEIN-A-I IS SECRETED BY THE HEPATO-CARCINOMA CELL-LINE HEP G2 [J].
EDELSTEIN, C ;
KAISER, M ;
PIRAS, G ;
SCANU, AM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1988, 267 (01) :23-30